Furosemide (Frusemide)
Brand names: Lasix, Frusol
Furosemide (frusemide) is a loop diuretic used for oedema in heart failure, renal and hepatic disease and for fluid overload; in older people the risks of dehydration, electrolyte disturbance and falls are heightened.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits the sodium-potassium-chloride co-transporter in the thick ascending limb of the loop of Henle, producing potent natriuresis and diuresis.
Prescribing in practice
- Older patients are prone to dehydration, hypotension, acute kidney injury and falls, so use the lowest effective dose, monitor volume status, and reassess during intercurrent illness using sick-day guidance.
- It can cause hypokalaemia, hyponatraemia and hypomagnesaemia, and worsens gout and glucose control; review potassium-affecting and nephrotoxic co-medications.
- High doses or rapid intravenous administration carry a risk of ototoxicity, particularly with renal impairment or other ototoxic drugs.
Monitoring
Monitor renal function, electrolytes, blood pressure, weight and fluid status, especially after dose changes or during acute illness.
Counselling the patient
- Take earlier in the day to avoid night-time urination disturbing sleep.
- Report dizziness, cramps, marked weakness or reduced urine output.
- During vomiting, diarrhoea or fever, seek advice as the dose may need pausing.
Evidence & guidelines
Loop diuretics are a long-established cornerstone of symptomatic congestion relief in heart failure, with cautious dosing in older adults supported by their pharmacology and electrolyte effects.
Reference: NICE NG106 Heart Failure; ESC HF Guidelines 2021; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5